Related Experiment Video
Updated: May 28, 2026

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
Blood pressure elevation in long-term survivors of pediatric liver transplantation
V A McLin1, R Anand, S R Daniels
1Department of Pediatrics, University Hospitals Geneva, Switzerland. valerie.mclin@hcuge.ch
Insights
Pediatric liver transplant (LT) survivors frequently experience elevated blood pressure (BP) between 5-10 years post-transplant. Factors like transplant age, steroid use, and kidney function impact BP outcomes.
Area of Science:
- Pediatric Nephrology
- Transplant Medicine
- Cardiovascular Health
Background:
- Long-term immunosuppression in pediatric liver transplant (LT) recipients can lead to chronic medical issues.
- Understanding the long-term complications, particularly cardiovascular health, is crucial as these patients mature.
Purpose of the Study:
- To determine the prevalence of elevated blood pressure (BP) in long-term pediatric LT survivors.
- To identify factors that predict elevated BP in this population.
Main Methods:
- Utilized data from the Studies in Pediatric Liver Transplantation (SPLIT) database.
- Analyzed BP measurements from 815 patients 5-10 years post-LT.
- Employed multivariate analysis to identify predictive factors for elevated BP.
Main Results:
- Prevalence of elevated BP ranged from 17.5% to 27.5% between 5-10 years post-LT.
- 62.5% of patients had at least one additional elevated BP reading during follow-up.
- Predictive factors for elevated BP included age at transplant, steroid use, and estimated glomerular filtration rate (eGFR).
Conclusions:
- Pediatric LT recipients exhibit a significant prevalence of elevated BP years after transplantation.
- Elevated BP is associated with specific factors including age at transplant, reduced kidney function, and recent steroid use.
Abstract:
As pediatric liver transplant (LT) recipients come of age, additional insight into long-term medical complications of immunosuppression is warranted. The aims of this study were to estimate the prevalence of elevated blood pressure (BP) in long-term survivors of pediatric LT using the data from the Studies in Pediatric Liver Transplantation (SPLIT) database and to identify predictive factors. Patients enrolled in the BP arm of the SPLIT cohort participated in the study. All patients were of at least 5 years but ≤10 years post-LT. Automated BP measurements were obtained at anniversary visits. BP measures were classified as normal, borderline or elevated according to standard criteria. Patients taking antihypertensive medications were classified as "elevated." Eight hundred and fifteen patients participated. The prevalence of elevated BP measurements 5 to 10 years post-LT was 17.5 to 27.5%. Of total 62.5% patients presented with at least one additional elevated BP at a later follow up visit. Multivariate analysis revealed the following parameters to be predictive of elevated BP: age at transplant, steroid use at last BP measurement and cGFR at last BP measurement. Pediatric LT patients show a high prevalence of elevated BP measurements 5 to 10 years following LT, which is related to age at LT, decreased cGFR and recent steroid use.
Related Concept Videos
Portal Hypertension
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Measurement of Blood Pressure
